1
|
Calò L, Crescenzi C, Martino A, Casella M, Romeo F, Cappelletto C, Bressi E, Panattoni G, Stolfo D, Targetti M, Toso E, Musumeci MB, Tini G, Ciabatti M, Stefanini M, Silvetti E, Stazi A, Danza ML, Rebecchi M, Canestrelli S, Fedele E, Lanzillo C, Fusco A, Sangiuolo FC, Oliviero G, Radesich C, Perotto M, Pieroni M, Golia P, Mango R, Gasperetti A, Autore C, Merlo M, de Ruvo E, Russo AD, Olivotto I, Sinagra G, Gaita F. The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG Signs. JACC Clin Electrophysiol 2023; 9:2615-2627. [PMID: 37768253 DOI: 10.1016/j.jacep.2023.08.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 07/27/2023] [Accepted: 08/17/2023] [Indexed: 09/29/2023]
Abstract
BACKGROUND Electrocardiographic (ECG) findings in arrhythmogenic left ventricular cardiomyopathy (ALVC) are limited to small case series. OBJECTIVES This study aimed to analyze the ECG characteristics of ALVC patients and to correlate ECG with cardiac magnetic resonance and genotype data. METHODS We reviewed data of 54 consecutive ALVC patients (32 men, age 39 ± 15 years) and compared them with 84 healthy controls with normal cardiac magnetic resonance. RESULTS T-wave inversion was often noted (57.4%), particularly in the inferior and lateral leads. Low QRS voltages in limb leads were observed in 22.2% of patients. The following novel ECG findings were identified: left posterior fascicular block (LPFB) (20.4%), pathological Q waves (33.3%), and a prominent R-wave in V1 with a R/S ratio ≥0.5 (24.1%). The QRS voltages were lower in ALVC compared with controls, particularly in lead I and II. At receiver-operating characteristic analysis, the sum of the R-wave in I to II ≤8 mm (AUC: 0.909; P < 0.0001) and S-wave in V1 plus R-wave in V6 ≤12 mm (AUC: 0.784; P < 0.0001) effectively discriminated ALVC patients from controls. It is noteworthy that 4 of the 8 patients with an apparently normal ECG were recognized by these new signs. Transmural late gadolinium enhancement was associated to LPFB, a R/S ratio ≥0.5 in V1, and inferolateral T-wave inversion, and a ringlike pattern correlated to fragmented QRS, SV1+RV6 ≤12 mm, low QRS voltage, and desmoplakin alterations. CONCLUSIONS Pathological Q waves, LPFB, and a prominent R-wave in V1 were common ECG signs in ALVC. An R-wave sum in I to II ≤8 mm and SV1+RV6 ≤12 mm were specific findings for ALVC phenotypes compared with controls.
Collapse
Affiliation(s)
- Leonardo Calò
- Division of Cardiology, Policlinico Casilino, Rome, Italy.
| | | | | | - Michela Casella
- Cardiology and Arrhythmology Clinic, University Cardiology Hospital Ospedali Riuniti, Ancona, Italy
| | - Fabiana Romeo
- Division of Cardiology, Policlinico Casilino, Rome, Italy
| | - Chiara Cappelletto
- Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy
| | - Edoardo Bressi
- Division of Cardiology, Policlinico Casilino, Rome, Italy
| | | | - Davide Stolfo
- Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy
| | - Mattia Targetti
- Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy
| | - Elisabetta Toso
- Division of Cardiology, Department of Medical Sciences, AOU Città della Salute e della Scienza Hospital, University of Turin, Turin, Italy
| | - Maria Beatrice Musumeci
- Cardiology Unit, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant'Andrea University Hospital, Rome, Italy
| | - Giacomo Tini
- Cardiology Unit, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant'Andrea University Hospital, Rome, Italy
| | | | | | - Elisa Silvetti
- Division of Cardiology, Policlinico Casilino, Rome, Italy
| | | | | | - Marco Rebecchi
- Division of Cardiology, Policlinico Casilino, Rome, Italy
| | | | - Elisa Fedele
- Division of Cardiology, Policlinico Casilino, Rome, Italy
| | | | - Armando Fusco
- Division of Radiology, Policlinico Casilino, Rome, Italy
| | | | - Giada Oliviero
- Division of Cardiology, Policlinico Casilino, Rome, Italy
| | - Cinzia Radesich
- Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy
| | - Maria Perotto
- Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy
| | | | - Paolo Golia
- Division of Cardiology, Policlinico Casilino, Rome, Italy
| | - Ruggiero Mango
- Cardiology Unit, Department of Emergency and Critical Care, Policlinico Tor Vergata, Rome, Italy
| | | | - Camillo Autore
- Cardiology Unit, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant'Andrea University Hospital, Rome, Italy
| | - Marco Merlo
- Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy
| | | | - Antonio Dello Russo
- Cardiology and Arrhythmology Clinic, University Cardiology Hospital Ospedali Riuniti, Ancona, Italy
| | - Iacopo Olivotto
- Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy; Cardiology Unit, Meyer University Children Hospital IRCCS, University of Florence, Florence, Italy
| | - Gianfranco Sinagra
- Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy
| | - Fiorenzo Gaita
- Division of Cardiology, Department of Medical Sciences, AOU Città della Salute e della Scienza Hospital, University of Turin, Turin, Italy
| |
Collapse
|
2
|
Calò L, Martino A, Bollettino M, Scialla L, Cicogna F, Tota C, Ponziani B, Oliviero G, Panuccio M, Fagagnini A, Toto F, Fanisio F, De Ruvo E. Heart failure and telemedicine: where are we and where are we going? Opportunities and critical issues. Eur Heart J Suppl 2023; 25:C326-C330. [PMID: 37125315 PMCID: PMC10132621 DOI: 10.1093/eurheartjsupp/suad029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Heart failure (HF) is one of the main causes of morbidity in the world and is responsible for an enormous amount of health costs, mostly due to hospitalizations. The remote control techniques of vital signs and health status have the potential to help prevent factors leading to HF instability by stimulating early therapeutic interventions. The goal of telemedicine is to change the intervention strategy from a 'reactive' type, in which therapy is optimized in response to the worsening of symptoms, to a 'pro-active' type, in which therapeutic changes are undertaken based on changes in the monitored parameters during the sub-clinical phase. This article is aimed at exploring the major results obtained by telemedicine application in HF patients with and without cardiac electronic devices or in those with haemodynamic sensors and to analyse the critical issues and the opportunities of its use.
Collapse
Affiliation(s)
- Leonardo Calò
- Corresponding author. Tel: +39 06 23188406, Fax: +39 06 23188410,
| | | | | | - Ludovica Scialla
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Francesco Cicogna
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Claudia Tota
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Beatrice Ponziani
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Giada Oliviero
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Marco Panuccio
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Alessandro Fagagnini
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Federica Toto
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Francesca Fanisio
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| | - Ermenegildo De Ruvo
- Division of Cardiology, Policlinic Casilino, Via Casilina 1049, Rome 00139, Italy
| |
Collapse
|
3
|
Calò L, Oliviero G, Crescenzi C, Romeo F, Martino A, Bressi E, Stefanini M, Silvetti E, Danza L, Rebecchi M, Canestrelli S, Fedele E, Lanzillo C, Fusco A, De Ruvo E. Electrocardiogram in arrhytmogenic cardiomyopathy. Eur Heart J Suppl 2023; 25:C169-C172. [PMID: 37125311 PMCID: PMC10132580 DOI: 10.1093/eurheartjsupp/suad019] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Criteria for diagnosis of arrhythmogenic cardiomyopathy (ACM) were first proposed in 1994 and subsequently revised in 2010 and in 2020 by an international task force. According to the last consensus of 2020, ACM is defined as a heart muscle disease affecting right ventricle, left ventricle or both, whose principal pathologic feature is fibrofatty myocardial replacement that impairs systolic ventricular function and predisposes to lethal ventricular arrhythmias. ECG findings not only could help to early recognize affected patients but also could identify the ones with maximum risk of ventricular arrhythmias and sudden cardiac death.
Collapse
Affiliation(s)
- Leonardo Calò
- Corresponding author. Tel: +39 06 23188406, Fax: +39 06 23188410,
| | - Giada Oliviero
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Cinzia Crescenzi
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Fabiana Romeo
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Annamaria Martino
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Edoardo Bressi
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Matteo Stefanini
- Division of Radiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Elisa Silvetti
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Ludovica Danza
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Marco Rebecchi
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Stefano Canestrelli
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Elisa Fedele
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Chiara Lanzillo
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Armando Fusco
- Division of Radiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| | - Ermenegildo De Ruvo
- Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy
| |
Collapse
|
4
|
Jordà P, Bosman LP, Gasperetti A, Mazzanti A, Gourraud JB, Davies B, Frederiksen TC, Moreno Weidmann Z, Di Marco A, Roberts JD, MacIntyre C, Seifer C, Delinière A, Alqarawi W, Kukavica D, Minois D, Trancuccio A, Arnaud M, Targetti M, Martino A, Oliviero G, Pipilas DC, Carbucicchio C, Compagnucci P, Dello Russo A, Olivotto I, Calò L, Lubitz SA, Cutler MJ, Chevalier P, Arbelo E, Priori SG, Healey JS, Calkins H, Casella M, Jensen HK, Tondo C, Tadros R, James CA, Krahn AD, Cadrin-Tourigny J. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator. Eur Heart J 2022; 43:3041-3052. [PMID: 35766180 PMCID: PMC9392650 DOI: 10.1093/eurheartj/ehac289] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Revised: 04/16/2022] [Accepted: 05/18/2022] [Indexed: 12/17/2022] Open
Abstract
AIMS Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk.com). This study aimed to externally validate this prediction model in a large international multicentre cohort and to compare its performance with the risk factor approach recommended for implantable cardioverter-defibrillator (ICD) use by published guidelines and expert consensus. METHODS AND RESULTS In a retrospective cohort of 429 individuals from 29 centres in North America and Europe, 103 (24%) experienced sustained VA during a median follow-up of 5.02 (2.05-7.90) years following diagnosis of ARVC. External validation yielded good discrimination [C-index of 0.70 (95% confidence interval-CI 0.65-0.75)] and calibration slope of 1.01 (95% CI 0.99-1.03). Compared with the three published consensus-based decision algorithms for ICD use in ARVC (Heart Rhythm Society consensus on arrhythmogenic cardiomyopathy, International Task Force consensus statement on the treatment of ARVC, and American Heart Association guidelines for VA and SCD), the risk calculator performed better with a superior net clinical benefit below risk threshold of 35%. CONCLUSION Using a large independent cohort of patients, this study shows that the ARVC risk model provides good prognostic information and outperforms other published decision algorithms for ICD use. These findings support the use of the model to facilitate shared decision making regarding ICD implantation in the primary prevention of SCD in ARVC.
Collapse
Affiliation(s)
- Paloma Jordà
- Cardiovascular Genetics Center, Montreal Heart Institute, Université de Montréal, Montréal, QC, Canada.,Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.,Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Laurens P Bosman
- Division of Heart and Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
| | - Alessio Gasperetti
- Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA
| | - Andrea Mazzanti
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.,Department of Molecular Cardiology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.,Department of Molecular Cardiology, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
| | | | - Brianna Davies
- Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, BC, Canada
| | - Tanja Charlotte Frederiksen
- Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.,Department of Clinical Medicine, Health, Aarhus University, Aarhus N, Denmark
| | - Zoraida Moreno Weidmann
- Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Universitat Autònoma de Barcelona, CIBERCV, Barcelona, Spain
| | - Andrea Di Marco
- Arrhythmia Unit, Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
| | - Jason D Roberts
- Population Health Research Institute, McMaster University, Hamilton, ON, Canada.,Division of Cardiology, Hamilton Health Sciences, Hamilton, ON, Canada.,Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, ON, Canada
| | - Ciorsti MacIntyre
- Cardiac Electrophysiology Service, Quenn Elisabeth II Health Sciences Center, Dalhousie University, Halifax, NS, Canada
| | - Colette Seifer
- St-Boniface Hospital, University of Manitoba, Winnipeg, MB, Canada
| | - Antoine Delinière
- National Reference Center for Inherited Arrhythmias of Lyon, Louis Pradel Cardiovascular Hospital, Hospices Civils de Lyon, Lyon, France
| | - Wael Alqarawi
- Cardiac Electrophysiology Service, Ottawa Heart Institute, University of Ottawa, Ottawa, ON, Canada
| | - Deni Kukavica
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.,Department of Molecular Cardiology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.,Department of Molecular Cardiology, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
| | - Damien Minois
- Department of Cardiology, Centre Hospitalier Universitaire Nantes, Nantes, France
| | - Alessandro Trancuccio
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.,Department of Molecular Cardiology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.,Department of Molecular Cardiology, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
| | - Marine Arnaud
- Department of Cardiology, Centre Hospitalier Universitaire Nantes, Nantes, France
| | - Mattia Targetti
- Cardiomyopathy Unit, Department of Cardiology, Careggi University Hospital, Florence, Italy
| | | | - Giada Oliviero
- Department of Cardiology, Policlinico Casilino, Rome, Italy
| | - Daniel C Pipilas
- Cardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA
| | - Corrado Carbucicchio
- Department of Clinical Electrophysiology and Cardiac Pacing Centro Cardiologico Monzino, IRCCSC, Milan, Italy
| | - Paolo Compagnucci
- Department of Biomedical Sciences and Public Health, Cardiology and Arrhythmology Clinic, University Hospital Umberto I-Salesi-Lancisi, Marche Polytechnic University, Ancona, Italy
| | - Antonio Dello Russo
- Department of Biomedical Sciences and Public Health, Cardiology and Arrhythmology Clinic, University Hospital Umberto I-Salesi-Lancisi, Marche Polytechnic University, Ancona, Italy
| | - Iacopo Olivotto
- Cardiomyopathy Unit, Department of Cardiology, Careggi University Hospital, Florence, Italy
| | - Leonardo Calò
- Department of Cardiology, Policlinico Casilino, Rome, Italy
| | - Steven A Lubitz
- Cardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA
| | - Michael J Cutler
- Intermountain Medical Center Heart Institute, Intermountain Medical Center, Murray, UT, USA
| | - Philippe Chevalier
- National Reference Center for Inherited Arrhythmias of Lyon, Louis Pradel Cardiovascular Hospital, Hospices Civils de Lyon, Lyon, France
| | - Elena Arbelo
- Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.,Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.,European Reference Network for rare, low prevalence and complex diseases of the heart - ERN GUARD-Heart
| | - Silvia Giuliana Priori
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.,Department of Molecular Cardiology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.,Department of Molecular Cardiology, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
| | - Jeffrey S Healey
- Population Health Research Institute, McMaster University, Hamilton, ON, Canada.,Division of Cardiology, Hamilton Health Sciences, Hamilton, ON, Canada
| | - Hugh Calkins
- Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA
| | - Michela Casella
- Department of Clinical, Special and Dental Sciences, Cardiology and Arrhythmology Clinic, University Hospital Umberto I-Salesi-Lancisi, MarchePolytechnic University, Ancona, Italy
| | - Henrik Kjærulf Jensen
- Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.,Department of Clinical Medicine, Health, Aarhus University, Aarhus N, Denmark
| | - Claudio Tondo
- Department of Clinical Electrophysiology and Cardiac Pacing Centro Cardiologico Monzino, IRCCSC, Milan, Italy.,Department of Biomedical, Surgical and Dentistry Sciences, University of Milan, Milan, Italy
| | - Rafik Tadros
- Cardiovascular Genetics Center, Montreal Heart Institute, Université de Montréal, Montréal, QC, Canada
| | - Cynthia A James
- Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA
| | - Andrew D Krahn
- Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, BC, Canada
| | - Julia Cadrin-Tourigny
- Cardiovascular Genetics Center, Montreal Heart Institute, Université de Montréal, Montréal, QC, Canada
| |
Collapse
|
5
|
Caravati F, Golino M, Damiani G, Oliviero G, Vecchi AL, Giuntini C, Paganini EM, De Ponti R. Active fixation coronary sinus lead in a patient with persistence of left superior vena cava. Clin Case Rep 2020; 8:1642-1646. [PMID: 32983468 PMCID: PMC7495820 DOI: 10.1002/ccr3.2966] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 04/08/2020] [Accepted: 04/23/2020] [Indexed: 11/30/2022] Open
Abstract
In patients with PLSVC, the use of an active fixation lead (like the Medtronic "Attain Stability") on the coronary sinus can lead to a successful and safe cardiac resynchronization, facilitating its positioning with a low long-term displacement rate.
Collapse
Affiliation(s)
- Fabrizio Caravati
- Department of Heart and VesselsOspedale di CircoloUniversity of InsubriaVareseItaly
| | - Michele Golino
- Department of Heart and VesselsOspedale di CircoloUniversity of InsubriaVareseItaly
| | - Giulia Damiani
- Department of Heart and VesselsOspedale di CircoloUniversity of InsubriaVareseItaly
| | - Giada Oliviero
- Department of Heart and VesselsOspedale di CircoloUniversity of InsubriaVareseItaly
| | | | - Chiara Giuntini
- Department of Heart and VesselsOspedale di CircoloUniversity of InsubriaVareseItaly
| | | | - Roberto De Ponti
- Department of Heart and VesselsOspedale di CircoloUniversity of InsubriaVareseItaly
| |
Collapse
|
6
|
Gangemi CMA, Alaimo S, Pulvirenti A, García-Viñuales S, Milardi D, Falanga AP, Fragalà ME, Oliviero G, Piccialli G, Borbone N, Ferro A, D'Urso A, Croce CM, Purrello R. Endogenous and artificial miRNAs explore a rich variety of conformations: a potential relationship between secondary structure and biological functionality. Sci Rep 2020; 10:453. [PMID: 31949213 PMCID: PMC6965629 DOI: 10.1038/s41598-019-57289-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Accepted: 12/23/2019] [Indexed: 12/22/2022] Open
Abstract
Mature microRNAs are short non-coding RNA sequences which upon incorporation into the RISC ribonucleoprotein complex, play a crucial role in regulation of gene expression. However, miRNAs can exist within the cell also as free molecules fulfilling their biological activity. Therefore, it is emerging that in addition to sequence even the structure adopted by mature miRNAs might play an important role to reach the target. Indeed, we analysed by several spectroscopic techniques the secondary structures of two artificial miRNAs selected by computational tool (miR-Synth) as best candidates to silence c-MET and EGFR genes and of two endogenous miRNAs (miR-15a and miR-15b) having the same seed region, but different biological activity. Our results demonstrate that both endogenous and artificial miRNAs can arrange in several 3D-structures which affect their activity and selectivity toward the targets.
Collapse
Affiliation(s)
- C M A Gangemi
- Department of Chemical Science, University of Catania, Viale A. Doria 6, 95125, Catania, Italy
| | - S Alaimo
- Bioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Italy c/o Department of Mathematics and Computer Science, Viale A. Doria 6, 95125, Catania, Italy
| | - A Pulvirenti
- Bioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Italy c/o Department of Mathematics and Computer Science, Viale A. Doria 6, 95125, Catania, Italy
| | | | - D Milardi
- Istituto di Cristallografia CNR, Via P. Gaifami 9, 95126, Catania, Italy
| | - A P Falanga
- Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Pansini 5, 80131, Napoli, Italy
| | - M E Fragalà
- Department of Chemical Science, University of Catania, Viale A. Doria 6, 95125, Catania, Italy
| | - G Oliviero
- Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Pansini 5, 80131, Napoli, Italy
| | - G Piccialli
- Department of Pharmacy, University of Naples Federico II, D. Montesano 49, 80131, Napoli, Italy
| | - N Borbone
- Department of Pharmacy, University of Naples Federico II, D. Montesano 49, 80131, Napoli, Italy
| | - A Ferro
- Bioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Italy c/o Department of Mathematics and Computer Science, Viale A. Doria 6, 95125, Catania, Italy.
| | - A D'Urso
- Department of Chemical Science, University of Catania, Viale A. Doria 6, 95125, Catania, Italy.
| | - C M Croce
- Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA
| | - R Purrello
- Department of Chemical Science, University of Catania, Viale A. Doria 6, 95125, Catania, Italy.
| |
Collapse
|
7
|
Rakhimov AV, Barabash AS, Basharina-Freshville A, Blot S, Bongrand M, Bourgeois C, Breton D, Breier R, Birdsall E, Brudanin VB, Burešova H, Busto J, Calvez S, Cascella M, Cerna C, Cesar JP, Chauveau E, Chopra A, Claverie G, De Capua S, Delalee F, Duchesneau D, Egorov VG, Eurin G, Evans JJ, Fajt L, Filosofov DV, Flack R, Garrido X, Gomez H, Guillon B, Guzowski P, Hodák R, Holý K, Huber A, Hugon C, Jeremie A, Jullian S, Karaivanov DV, Kauer M, Klimenko AA, Kochetov OI, Konovalov SI, Kovalenko V, Lang K, Lemière Y, Le Noblet T, Liptak Z, Liu XR, Loaiza P, Lutter G, Maalmi J, Macko M, Mamedov F, Marquet C, Mauger F, Minotti A, Mirsagatova AA, Mirzayev NA, Moreau I, Morgan B, Mott J, Nemchenok IB, Nomachi M, Nova F, Ohsumi H, Oliviero G, Pahlka RB, Pater JR, Palušová V, Perrot F, Piquemal F, Povinec P, Pridal P, Ramachers YA, Rebii A, Remoto A, Richards B, Ricol JS, Rukhadze E, Rukhadze NI, Saakyan R, Sadikov II, Salazar R, Sarazin X, Sedgbeer J, Shitov YA, Šimkovic F, Simard L, Smetana A, Smolek K, Smolnikov AA, Snow S, Söldner-Rembold S, Soulé B, Špavorova M, Štekl I, Tashimova FA, Thomas J, Timkin V, Torre S, Tretyak VI, Tretyak VI, Umatov VI, Vilela C, Vorobel V, Warot G, Waters D, Zampaolo M, Žukauskas A. Development of methods for the preparation of radiopure 82Se sources for the SuperNEMO neutrinoless double-beta decay experiment. RADIOCHIM ACTA 2019. [DOI: 10.1515/ract-2019-3129] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
A radiochemical method for producing 82Se sources with an ultra-low level of contamination of natural radionuclides (40K, decay products of 232Th and 238U) has been developed based on cation-exchange chromatographic purification with reverse removal of impurities. It includes chromatographic separation (purification), reduction, conditioning (which includes decantation, centrifugation, washing, grinding, and drying), and 82Se foil production. The conditioning stage, during which highly dispersed elemental selenium is obtained by the reduction of purified selenious acid (H2SeO3) with sulfur dioxide (SO2) represents the crucial step in the preparation of radiopure 82Se samples. The natural selenium (600 g) was first produced in this procedure in order to refine the method. The technique developed was then used to produce 2.5 kg of radiopure enriched selenium (82Se). The produced 82Se samples were wrapped in polyethylene (12 μm thick) and radionuclides present in the sample were analyzed with the BiPo-3 detector. The radiopurity of the plastic materials (chromatographic column material and polypropylene chemical vessels), which were used at all stages, was determined by instrumental neutron activation analysis. The radiopurity of the 82Se foils was checked by measurements with the BiPo-3 spectrometer, which confirmed the high purity of the final product. The measured contamination level for 208Tl was 8–54 μBq/kg, and for 214Bi the detection limit of 600 μBq/kg has been reached.
Collapse
Affiliation(s)
- Alimardon V. Rakhimov
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
- Institute of Nuclear Physics of Uzbekistan Academy of Sciences , Tashkent , 100214 , Uzbekistan
| | - A. S. Barabash
- NRC “Kurchatov Institute”, ITEP , 117218 Moscow , Russia
| | | | - S. Blot
- University of Manchester , Manchester M13 9PL , UK
| | - M. Bongrand
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - Ch. Bourgeois
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - D. Breton
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - R. Breier
- Faculty of Mathematics, Physics and Informatics , Comenius University , SK-842 48 Bratislava , Slovakia
| | - E. Birdsall
- University of Manchester , Manchester M13 9PL , UK
| | - V. B. Brudanin
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
- National Research Nuclear University MEPhI , 115409 Moscow , Russia
| | | | - J. Busto
- CPPM, Universite d’Aix Marseille, CNRS/IN2P3 , F-13288 Marseille , France
| | - S. Calvez
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - M. Cascella
- University College London , London WC1E 6BT , UK
| | - C. Cerna
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - J. P. Cesar
- University of Texas at Austin , Austin, TX 78712 , USA
| | - E. Chauveau
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - A. Chopra
- University College London , London WC1E 6BT , UK
| | - G. Claverie
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - S. De Capua
- University of Manchester , Manchester M13 9PL , UK
| | - F. Delalee
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - D. Duchesneau
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc , CNRS/IN2P3, LAPP, 74000 Annecy , France
| | - V. G. Egorov
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - G. Eurin
- University College London , London WC1E 6BT , UK
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - J. J. Evans
- University of Manchester , Manchester M13 9PL , UK
| | - L. Fajt
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | - D. V. Filosofov
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - R. Flack
- University College London , London WC1E 6BT , UK
| | - X. Garrido
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - H. Gomez
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - B. Guillon
- LPC Caen, ENSICAEN, Université de Caen , CNRS/IN2P3, F-14050 Caen , France
| | - P. Guzowski
- University of Manchester , Manchester M13 9PL , UK
| | - R. Hodák
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | - K. Holý
- Faculty of Mathematics, Physics and Informatics , Comenius University , SK-842 48 Bratislava , Slovakia
| | - A. Huber
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - C. Hugon
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - A. Jeremie
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc , CNRS/IN2P3, LAPP, 74000 Annecy , France
| | - S. Jullian
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - D. V. Karaivanov
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
- Institute for Nuclear Research and Nuclear Energy (INRNE) , 72 Tzarigradsko chaussee, Blvd., BG-1784 Sofia , Bulgaria
| | - M. Kauer
- University College London , London WC1E 6BT , UK
| | - A. A. Klimenko
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - O. I. Kochetov
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | | | - V. Kovalenko
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - K. Lang
- University of Texas at Austin , Austin, TX 78712 , USA
| | - Y. Lemière
- LPC Caen, ENSICAEN, Université de Caen , CNRS/IN2P3, F-14050 Caen , France
| | - T. Le Noblet
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc , CNRS/IN2P3, LAPP, 74000 Annecy , France
| | - Z. Liptak
- University of Texas at Austin , Austin, TX 78712 , USA
| | - X. R. Liu
- University College London , London WC1E 6BT , UK
| | - P. Loaiza
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - G. Lutter
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - J. Maalmi
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - M. Macko
- Faculty of Mathematics, Physics and Informatics , Comenius University , SK-842 48 Bratislava , Slovakia
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | - F. Mamedov
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | - C. Marquet
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - F. Mauger
- LPC Caen, ENSICAEN, Université de Caen , CNRS/IN2P3, F-14050 Caen , France
| | - A. Minotti
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc , CNRS/IN2P3, LAPP, 74000 Annecy , France
| | - A. A. Mirsagatova
- Institute of Nuclear Physics of Uzbekistan Academy of Sciences , Tashkent , 100214 , Uzbekistan
| | - N. A. Mirzayev
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
- Institute of Radiation Problems of Azerbaijan National Academy of Sciences , AZ1143 B. Vahabzade 9 , Baku , Azerbaijan
| | - I. Moreau
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - B. Morgan
- University of Warwick , Coventry CV4 7AL , UK
| | - J. Mott
- University College London , London WC1E 6BT , UK
| | - I. B. Nemchenok
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - M. Nomachi
- Osaka University , 1-1 Machikaney arna Toyonaka , Osaka 560-0043 , Japan
| | - F. Nova
- University of Texas at Austin , Austin, TX 78712 , USA
| | - H. Ohsumi
- Saga University , Saga 840-8502 , Japan
| | - G. Oliviero
- LPC Caen, ENSICAEN, Université de Caen , CNRS/IN2P3, F-14050 Caen , France
| | - R. B. Pahlka
- University of Texas at Austin , Austin, TX 78712 , USA
| | - J. R. Pater
- University of Manchester , Manchester M13 9PL , UK
| | - V. Palušová
- Faculty of Mathematics, Physics and Informatics , Comenius University , SK-842 48 Bratislava , Slovakia
| | - F. Perrot
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - F. Piquemal
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - P. Povinec
- Faculty of Mathematics, Physics and Informatics , Comenius University , SK-842 48 Bratislava , Slovakia
| | - P. Pridal
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | | | - A. Rebii
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - A. Remoto
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc , CNRS/IN2P3, LAPP, 74000 Annecy , France
| | - B. Richards
- University College London , London WC1E 6BT , UK
| | - J. S. Ricol
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - E. Rukhadze
- Faculty of Mathematics, Physics and Informatics , Comenius University , SK-842 48 Bratislava , Slovakia
| | - N. I. Rukhadze
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - R. Saakyan
- University College London , London WC1E 6BT , UK
| | - I. I. Sadikov
- Institute of Nuclear Physics of Uzbekistan Academy of Sciences , Tashkent , 100214 , Uzbekistan
| | - R. Salazar
- University of Texas at Austin , Austin, TX 78712 , USA
| | - X. Sarazin
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
| | - J. Sedgbeer
- Imperial College London , London SW7 2AZ , UK
| | - Yu. A. Shitov
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - F. Šimkovic
- Faculty of Mathematics, Physics and Informatics , Comenius University , SK-842 48 Bratislava , Slovakia
| | - L. Simard
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay , F-91405 Orsay , France
- Institut Universitaire de France , F-75005 Paris , France
| | - A. Smetana
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | - K. Smolek
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | - A. A. Smolnikov
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - S. Snow
- University of Warwick , Coventry CV4 7AL , UK
| | | | - B. Soulé
- CENBG, Université de Bordeaux, CNRS/IN2P3 , F-33175 Gradignan , France
| | - M. Špavorova
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | - I. Štekl
- Institute of Experimental and Applied Physics , Czech Technical University in Prague , CZ-12800 Prague , Czech Republic
| | - F. A. Tashimova
- Institute of Nuclear Physics of Uzbekistan Academy of Sciences , Tashkent , 100214 , Uzbekistan
| | - J. Thomas
- University College London , London WC1E 6BT , UK
| | - V. Timkin
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - S. Torre
- University College London , London WC1E 6BT , UK
| | | | - V. I. Tretyak
- Joint Institute for Nuclear Research (JINR) , Dubna , 141980 , Russian Federation
| | - V. I. Umatov
- NRC “Kurchatov Institute”, ITEP , 117218 Moscow , Russia
| | - C. Vilela
- University College London , London WC1E 6BT , UK
| | - V. Vorobel
- Charles University, Prague, Faculty of Mathematics and Physics , CZ-12116 Prague , Czech Republic
| | - G. Warot
- Univ. Grenoble Alpes, CNRS, Grenoble INP , LPSC-IN2P3, 38000 Grenoble , France
| | - D. Waters
- University College London , London WC1E 6BT , UK
| | - M. Zampaolo
- Univ. Grenoble Alpes, CNRS, Grenoble INP , LPSC-IN2P3, 38000 Grenoble , France
| | - A. Žukauskas
- Charles University, Prague, Faculty of Mathematics and Physics , CZ-12116 Prague , Czech Republic
| |
Collapse
|
8
|
Nici F, Oliviero G, Falanga AP, D'Errico S, Marzano M, Musumeci D, Montesarchio D, Noppen S, Pannecouque C, Piccialli G, Borbone N. Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides. Org Biomol Chem 2019. [PMID: 29543291 DOI: 10.1039/c7ob02346d] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
By combining the ability of short G-rich oligodeoxyribonucleotides (ODNs) containing the sequence 5'CGGA3' to form higher order G-quadruplex (G4) complexes with the tetra-end-linked (TEL) concept to produce aptamers targeting the HIV envelope glycoprotein 120 (gp120), three new TEL-ODNs (1-3) having the sequence 5'CGGAGG3' were synthesized with the aim of studying the effect of G4 dimerization on their anti-HIV activity. Furthermore, in order to investigate the effect of the groups at the 5' position, the 5' ends of 1-3 were left uncapped (1) or capped with either the lipophilic dimethoxytrityl (DMT) (2) or the hydrophilic glucosyl-4-phosphate (3) moieties. The here reported results demonstrate that only the DMT-substituted TEL-ODN 2 is effective in protecting human MT-4 cell cultures from HIV infection (76% max protection), notwithstanding all the three new aptamers proved to be capable of forming stable higher order dimeric G4s when annealed in K+-containing buffer, thus suggesting that the recognition of a hydrophobic pocket on the target glycoprotein by the aptamers represents a main structural feature for triggering their anti-HIV activity.
Collapse
Affiliation(s)
- F Nici
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy.
| | - G Oliviero
- Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Napoli, Italy
| | - A P Falanga
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy.
| | - S D'Errico
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy.
| | - M Marzano
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy.
| | - D Musumeci
- Department of Chemical Sciences, University of Naples Federico II, Napoli, Italy
| | - D Montesarchio
- Department of Chemical Sciences, University of Naples Federico II, Napoli, Italy
| | - S Noppen
- KU Leuven, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, B-3000 Leuven, Belgium
| | - C Pannecouque
- KU Leuven, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, B-3000 Leuven, Belgium
| | - G Piccialli
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy.
| | - N Borbone
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy.
| |
Collapse
|
9
|
Aicale R, Tarantino D, Oliviero G, Maccauro G, Peretti GM, Maffulli N. O'nil Anteversa® mini-plate for stable hip fracture: first experience considerations and outcomes. J BIOL REG HOMEOS AG 2019; 33:147-154. XIX Congresso Nazionale S.I.C.O.O.P. Societa' Italiana Chirurghi Ortopedici Dell'ospedalita' Privata Accreditata. [PMID: 31172732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Hip fractures are associated with a 20% one-year mortality and a 50% loss of function. Over 700,000 deaths are estimated to occur annually worldwide following hip fractures. Concern exist regarding which is the best implant for extracapsular fractures fixation. For a correct positioning of the cephalic screw, a new plate (O'Nil Anteversa® mini-plate, Intrauma, Torino, Italy) with a fixed 8°of anteversion in the axial plane was developed. A total of 22 patients with an intertrochanteric fracture underwent surgery with Anteversa® mini-plate between October 2016 and April 2017. Data collected included patients' age at surgery, gender, fracture type, operative side, surgeon, type of implant, TAD, CalTAD and TADCalTAD. All patients underwent clinical and radiographic evaluations according to the AO Surgery Reference classification. The mean TAD, CalTAD and TADcalTAD for the entire population of study were, respectively, 20.18±7.5 mm, 20.45±7.25 mm, and 40.62±14.44 mm. The mean TAD, CalTAD and TADcalTAD of those patients who experienced mobilisation of the cephalic screw were, respectively, 20.26±5.87 mm, 19.53±5.47 mm, and 39.8±11.16 mm. Three patients experienced mobilisation of the cephalic screw, and none of these had a TAD greater than 25 mm, a CalTAD greater of 25mm or a TADcalTAD greater than 50 mm. This type of device meets the essential requirements for a correct treatment of intertrochanteric fractures in elderly patients. However, the excessive need of attention in each step, and the consequent increased time of surgery, could be seen as a limitation for its use.
Collapse
Affiliation(s)
- R Aicale
- Department of Musculoskeletal Disorders, Faculty of Medicine and Surgery, University of Salerno, Baronissi, Italy
- Clinica Ortopedica, Ospedale San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy
| | - D Tarantino
- Department of Musculoskeletal Disorders, Faculty of Medicine and Surgery, University of Salerno, Baronissi, Italy
| | - G Oliviero
- Clinica Ortopedica, Ospedale San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy
| | - G Maccauro
- A. Gemelli University Hospital Foundation IRCCS, Catholic University, Roma, Italy
- Università Cattolica del Sacro Cuore, Roma, Italy
| | - G M Peretti
- IRCCS Istituto Ortopedico Galeazzi, Milan, Italy
- Department of Biomedical Sciences for Health, University of Milan, Milan, Italy
| | - N Maffulli
- Department of Musculoskeletal Disorders, Faculty of Medicine and Surgery, University of Salerno, Baronissi, Italy
- Clinica Ortopedica, Ospedale San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy
- Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, Mile End Hospital, London, England
- Keele University, School of Medicine, Institute of Science and Technology in Medicine, Guy Hilton Research Centre, Hartshill, Stoke-on-Trent, England
| |
Collapse
|
10
|
Girard P, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz P, Revel M, Westeel V, Dixmier A, Trédaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria J, Friard S, Caliandro R, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani J, De Luca K, Jouveshomme S, Jebrak G, Poudenx M, Vaylet F, Igual J, Daniel C, Alifano M, Chatelier G, Meyer G. Effet anti-tumoral d’une héparine de bas poids moléculaire dans le cancer bronchique localisé : l’essai Tinzaparin In Lung Tumors (TILT). Rev Mal Respir 2018. [DOI: 10.1016/j.rmr.2017.10.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Auliac J, Guisier F, Robinet G, Oliviero G, Thomas P, Baize N, Chouaid C, Corre R. Tolérance et efficacité en monde réel des inhibiteurs tyrosine-kinase (TKI) de l’EGFR chez les patients octogénaires atteints de cancer du poumon non à petites cellules (CPNPC) porteurs d’une mutation activatrice de l’EGFR. Étude OCTOMUT GFPC 07-15. Rev Mal Respir 2018. [DOI: 10.1016/j.rmr.2017.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
12
|
Besse B, Girard P, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz PE, Revel MP, Westeel V, Alifano M, Chatellier G, Meyer G. Antitumoral effect of low molecular weight heparin in localized lung cancer. A randomized phase III controlled trial. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx669.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
13
|
D'Urso A, Randazzo R, Rizzo V, Gangemi CMA, Romanucci V, Zarrelli A, Tomaselli G, Milardi D, Borbone N, Purrello R, Piccialli G, Di Fabio G, Oliviero G. Stabilization vs. destabilization of G-quadruplex superstructures: the role of the porphyrin derivative having spermine arms. Phys Chem Chem Phys 2017. [PMID: 28650039 DOI: 10.1039/c7cp02816d] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The interaction of the porphyrin derivative H2TCPPSpm4, having spermine pendants in the four meso positions, with the G-quadruplex (GQ) structure formed by the DNA aptamer TGGGAG has been investigated by means of UV, electronic circular dichroism and PAGE studies. The results reported here demonstrate that the porphyrin derivative is capable of stabilizing or destabilizing the higher-ordered structures of parallel GQs, depending on the method used to reach their relative stoichiometry (titration vs. single addition). Noteworthily, when two equivalents of H2TCPPSpm4 were mixed directly with one equivalent of the (TGGGAG)4 GQ to reach a 2 : 1 H2TCPPSpm4 : GQ ratio T1/2 higher than 80 °C was also observed confirming the presence of higher-ordered GQ structures.
Collapse
Affiliation(s)
- A D'Urso
- Department of Chemical Science, University of Catania, V.le A Doria 6, 95125, Catania, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Magrì D, Santolamazza C, Limite L, Mastromarino V, Casenghi M, Orlando P, Pagannone E, Musumeci MB, Maruotti A, Ricotta A, Oliviero G, Piccirillo G, Volpe M, Autore C. QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal. J Cardiol 2017; 70:310-315. [PMID: 28341542 DOI: 10.1016/j.jjcc.2017.01.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2016] [Revised: 01/17/2017] [Accepted: 01/27/2017] [Indexed: 01/18/2023]
Abstract
BACKGROUND The 12-lead surface electrocardiographic (ECG) analysis is able to provide independent predictors of prognosis in several cardiovascular settings, including hypertrophic cardiomyopathy (HCM). The present single-center study investigated the possible ability of several ECG-derived variables in stratifying sudden cardiac death (SCD) risk and, possibly, in improving the accuracy of the 2014 European Society of Cardiology guidelines. METHODS A total of 221 consecutive HCM outpatients were recruited and prospectively followed. All of them underwent a full clinical and instrumental examination, including a 12-lead surface ECG to calculate the dispersion for the following intervals: QRS, Q-Tend (QT), Q-Tpeak (QTp), Tpeak-Tend (TpTe), J-Tpeak (JTp), and J-Tend (JT). The study composite end-point was SCD, aborted SCD, and appropriate implantable cardioverter defibrillator (ICD) interventions. RESULTS During a median follow-up of 4.4 years (25th-75th interquartile range: 2.4-9.4 years), 23 patients reached the end-point at 5-years (3 SCD, 3 aborted SCD, 17 appropriate ICD interventions). At multivariate analysis, the spatial QT dispersion corrected according to Bazett's formula (QTcd) remains independently associated to the study endpoint over the HCM Risk-SCD score (C-index 0.737). A QTcd cut-off value of 93ms showed the best accuracy in predicting the SCD endpoint within the entire HCM study cohort (sensitivity 56%, specificity 75%, positive predictive value 22%, negative predictive value 97%). CONCLUSION Our data suggest that the QTcd might be helpful in SCD risk stratification, particularly in those HCM categories classified at low-intermediate SCD risk according to the contemporary guidelines.
Collapse
Affiliation(s)
- Damiano Magrì
- Department of Clinical and Molecular Medicine, "Sapienza" University, Rome, Italy.
| | | | - Luca Limite
- Department of Clinical and Molecular Medicine, "Sapienza" University, Rome, Italy
| | | | - Matteo Casenghi
- Department of Clinical and Molecular Medicine, "Sapienza" University, Rome, Italy
| | - Paola Orlando
- Department of Clinical and Molecular Medicine, "Sapienza" University, Rome, Italy
| | - Erika Pagannone
- Department of Clinical and Molecular Medicine, "Sapienza" University, Rome, Italy
| | | | - Antonello Maruotti
- Department of Scienze Economiche, Politiche e delle Lingue Moderne, Libera Università SS Maria Assunta, Rome, Italy; Centre for Innovation and Leadership in Health Sciences, University of Southampton, Southampton, UK
| | - Agnese Ricotta
- Department of Clinical and Molecular Medicine, "Sapienza" University, Rome, Italy
| | - Giada Oliviero
- Department of Cardiovascular Sciences, University of Insubria, Varese, Italy
| | - Gianfranco Piccirillo
- Department of Cardiovascular, Respiratory, Anesthesiological, Nephrologic and Geriatrics Sciences, "Sapienza" University, Rome, Italy
| | - Massimo Volpe
- Department of Clinical and Molecular Medicine, "Sapienza" University, Rome, Italy; IRCCS, Neuromed, Pozzilli (IS), Italy
| | - Camillo Autore
- Department of Clinical and Molecular Medicine, "Sapienza" University, Rome, Italy
| |
Collapse
|
15
|
De Chiara L, Andrews D, Watson A, Oliviero G, Cagney G, Crean J. miR302 regulates SNAI1 expression to control mesangial cell plasticity. Sci Rep 2017; 7:42407. [PMID: 28195240 PMCID: PMC5307964 DOI: 10.1038/srep42407] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Accepted: 01/09/2017] [Indexed: 01/04/2023] Open
Abstract
Cell fate decisions are controlled by the interplay of transcription factors and epigenetic modifiers, which together determine cellular identity. Here we elaborate on the role of miR302 in the regulation of cell plasticity. Overexpression of miR302 effected silencing of the TGFβ type II receptor and facilitated plasticity in a manner distinct from pluripotency, characterized by increased expression of Snail. miR302 overexpressing mesangial cells also exhibited enhanced expression of EZH2 coincident with Snail upregulation. esiRNA silencing of each component suggest that Smad3 and EZH2 are part of a complex that regulates plasticity and that miR302 regulates EZH2 and Snail independently. Subsequent manipulation of miR302 overexpressing cells demonstrated the potential of using this approach for reprogramming as evidenced by de novo expression of the tight junction components ZO-1 and E-cadherin and the formation of ZO-1 containing tight junctions. Understanding the processes through which dynamic epigenetic silencing is controlled in adults cells will allow us to address the epigenetic state of acquired disease and whether original states, regenerative in nature, can be restored with therapy.
Collapse
Affiliation(s)
- L De Chiara
- UCD Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Science, Dublin, Ireland.,UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland.,Weill Cornell Medical College (WCMC), Department of Surgery, 1300 York Avenue, 10065 New York (NY), USA
| | - D Andrews
- UCD Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Science, Dublin, Ireland.,UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland
| | - A Watson
- UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland
| | - G Oliviero
- UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland.,Syddansk Universitet - Odense Universitet Institut for Biokemi og Molekylær Biologi, Danmark
| | - G Cagney
- UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland
| | - J Crean
- UCD Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Science, Dublin, Ireland.,UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland
| |
Collapse
|
16
|
Denis M, Lafourcade M, Le Garff G, Dayen C, Falchero L, Thomas P, Locher C, Fraboulet G, Oliviero G, Licour M, Normanno N, Reck M, Molinier O. Circulating free tumour-derived DNA (ctDNA) to detect EGFR mutation in patients (pts) with advanced NSCLC (aNSCLC): French subset analysis of the ASSESS study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw363.09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
17
|
Mazza R, Tramontana S, Bergese P, Oliviero G, Depero L, Ajmone-Marsan P. Analysis of livestock DNA using nanotechnologies. Italian Journal of Animal Science 2016. [DOI: 10.4081/ijas.2007.1s.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Affiliation(s)
- R. Mazza
- Unità Latemar. Università Cattolica del Sacro Cuore, Piacenza, Italy
- Istituto di Zootecnica. Università Cattolica del Sacro Cuore, Piacenza, Italy
| | - S. Tramontana
- Istituto di Zootecnica. Università Cattolica del Sacro Cuore, Piacenza, Italy
| | - P. Bergese
- INSTM and Chemistry for Technologies Laboratory, University of Brescia, Brescia, Italy
| | - G. Oliviero
- INSTM and Chemistry for Technologies Laboratory, University of Brescia, Brescia, Italy
| | - L. Depero
- INSTM and Chemistry for Technologies Laboratory, University of Brescia, Brescia, Italy
| | - P. Ajmone-Marsan
- Istituto di Zootecnica. Università Cattolica del Sacro Cuore, Piacenza, Italy
| |
Collapse
|
18
|
Raynaud C, Greillier L, Mazieres J, Monnet I, Mastroianni B, Robinet G, Fraboulet G, Dixmier A, Berard H, Lamy R, Letreut J, Lena H, Oliviero G, Botta S, Vergnenegre A, Borget I, Chouaid C. Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study). BMC Cancer 2015; 15:857. [PMID: 26546402 PMCID: PMC4635998 DOI: 10.1186/s12885-015-1881-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2015] [Accepted: 10/30/2015] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Malignant pleural mesothelioma (MPM) is a rare disease with poor prognosis in spite of significant improvement in survival, due to new chemotherapy regimens. We describe here patients' profiles and management in daily practice in France. METHODS Observational retrospective study. Data were collected from medical files. All patients with histologically proven MPM diagnosed from January 2005 to December 2008 were included in the participating sites. RESULTS Four hundred and six patients were included in 37 sites: mean age 68.9 ± 9.8 years, male predominance (sex ratio 3.27), latency of the disease 45.7 years, epithelioïd type 83 %. Diagnosis was made using thoracoscopy in 80.8 % of patients. Radical surgery was performed in 6.2 % of cases. Chemotherapy was administered to 74.6 % of patients. First line regimens consisted mainly of platinum + pemetrexed (91 %) or pemetrexed alone (7 %). Objective response rate was 17.2 % and another 41.6 % of patients experienced disease stabilization. Half of these patients underwent second line chemotherapy (platinium + pemetrexed 31.6 %, pemetrexed alone 24.6 %), resulting in a 6 % response rate. Third-line chemotherapy (56 patients) yielded disease control in 5.4 % of cases. CONCLUSIONS The management of MPM in France is usually in accordance with guidelines. Response rates are somewhat lower than those described in clinical trials.
Collapse
Affiliation(s)
- C Raynaud
- Service de Pneumologie, CH Argenteuil, Argenteuil, France.
| | - L Greillier
- Service d'oncologie thoracique, APHM, Marseille, Services de Pneumologie, Marseille, France.
| | | | - I Monnet
- Service de pneumologie, CHI Créteil, 40 avenue de verdun, 94010, Créteil, France.
| | | | | | | | | | | | - R Lamy
- CH Lorient, Lorient, France.
| | - J Letreut
- CH Aix en Provence, Aix en Provence, France.
| | - H Lena
- CHU Rennes, Rennes, France.
| | | | | | | | | | - C Chouaid
- Service de pneumologie, CHI Créteil, 40 avenue de verdun, 94010, Créteil, France.
| |
Collapse
|
19
|
Scuotto M, Persico M, Bucci M, Vellecco V, Borbone N, Morelli E, Oliviero G, Novellino E, Piccialli G, Cirino G, Varra M, Fattorusso C, Mayol L. Outstanding effects on antithrombin activity of modified TBA diastereomers containing an optically pure acyclic nucleotide analogue. Org Biomol Chem 2015; 12:5235-42. [PMID: 24920241 DOI: 10.1039/c4ob00149d] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Herein, we report optically pure modified acyclic nucleosides as ideal probes for aptamer modification. These new monomers offer unique advantages in exploring the role played in thrombin inhibition by a single residue modification at key positions of the TBA structure.
Collapse
Affiliation(s)
- M Scuotto
- Dipartimento di Farmacia, via D. Montesano 49, 80131 Napoli, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Magrì D, Piccirillo G, Ricotta A, De Cecco CN, Mastromarino V, Serdoz A, Muscogiuri G, Gregori M, Casenghi M, Cauti FM, Oliviero G, Musumeci MB, Maruotti A, Autore C. Spatial QT Dispersion Predicts Nonsustained Ventricular Tachycardia and Correlates with Confined Systodiastolic Dysfunction in Hypertrophic Cardiomyopathy. Cardiology 2015; 131:122-9. [DOI: 10.1159/000377622] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Accepted: 01/28/2015] [Indexed: 11/19/2022]
Abstract
Objectives: An increased dispersion of myocardial repolarization represents one of the mechanisms underlying the arrhythmic risk in hypertrophic cardiomyopathy (HCM). We investigated spatial myocardial repolarization dispersion indices in HCM patients with nonsustained ventricular tachycardia (NSVT) and, contextually, their main clinical determinants. Methods: Fifty-two well-matched HCM outpatients were categorized into two groups according to the presence or the absence of NSVT at 24-hour Holter electrocardiogram (ECG) monitoring. Each patient underwent a clinical examination, including Doppler echocardiogram integrated with tissue Doppler imaging, cardiac magnetic resonance, and 12-lead surface ECG to calculate the dispersion for the following intervals: QRS, Q-Tend (QTe), Q-Tpeak, Tpeak-Tend (TpTe), J-Tpeak, and J-Tend. Results: The NSVT group showed only QTe dispersion and TpTe dispersion values to be significantly higher than their counterparts. NSVT occurrence was independently predicted by late gadolinium enhancement presence (p = 0.021) and QTe Bazett dispersion (p = 0.030), the latter strongly associated with the myocardial performance index (MPI) obtained at the basal segment of the interventricular septum (p = 0.0004). Conclusion: Our data support QTe dispersion as an easy and noninvasive tool for identifying HCM patients with NSVT propensity. The strong relationship between QTe dispersion and MPI allows us to hypothesize an intriguing link between electrical instability and confined myocardial areas of systodiastolic dysfunction.
Collapse
|
21
|
Moran T, Wei J, Cobo M, Qian X, Domine M, Zou Z, Bover I, Wang L, Provencio M, Yu L, Chaib I, You C, Massuti B, Song Y, Vergnenegre A, Lu H, Lopez-Vivanco G, Hu W, Robinet G, Yan J, Insa A, Xu X, Majem M, Chen X, de Las Peñas R, Karachaliou N, Sala MA, Wu Q, Isla D, Zhou Y, Baize N, Zhang F, Garde J, Germonpre P, Rauh S, ALHusaini H, Sanchez-Ronco M, Drozdowskyj A, Sanchez JJ, Camps C, Liu B, Rosell R, Colinet B, De Grève J, Germonpré P, Chen H, Chen X, Du J, Gao Y, Hu J, Hu W, Kong W, Li L, Li R, Li X, Liu B, Liu J, Lu H, Qian X, Ren W, Song Y, Wang L, Wei J, Wen L, Wu Q, Xiao X, Xu X, Yan J, Yang J, Yang M, Yang Y, Yin J, You C, Yu L, Yue X, Zhang F, Zhang J, Zhou Y, Zhu L, Zou Z, Baize N, Bombaron P, Chouaid C, Dansin E, Fournel P, Fraboulet G, Gervais R, Hominal S, Kahlout S, Lecaer H, Lena H, LeTreut J, Locher C, Molinier O, Monnet I, Oliviero G, Robinet G, Schoot R, Thomas P, Vergnènegre A, Berchem G, Rauh S, Al Husaini H, Aparisi F, Arriola E, Ballesteros I, Barneto I, Bernabé R, Blasco A, Bosch-Barrera J, Bover I, Calvo de Juan V, Camps C, Carcereny E, Catot S, Cobo M, De Las Peñas R, Dómine M, Felip E, García-Campelo MR, García-Girón C, García-Gómez R, Garcia-Sevila R, Garde J, Gasco A, Gil J, González-Larriba JL, Hernando-Polo S, Jantus E, Insa A, Isla D, Jiménez B, Lianes P, López-López R, López-Martín A, López-Vivanco G, Macias JA, Majem M, Marti-Ciriquian JL, Massuti B, Montoyo R, Morales-Espinosa D, Morán T, Moreno MA, Pallares C, Parera M, Pérez-Carrión R, Porta R, Provencio M, Reguart N, Rosell R, Rosillo F, Sala MA, Sanchez JM, Sullivan I, Terrasa J, Trigo JM, Valdivia J, Viñolas N, Viteri S, Botia-Castillo M, Mate JL, Perez-Cano M, Ramirez JL, Sanchez-Rodriguez B, Taron M, Tierno-Garcia M, Mijangos E, Ocaña J, Pereira E, Shao J, Sun X, O'Brate R. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies. Ann Oncol 2014; 25:2147-2155. [PMID: 25164908 DOI: 10.1093/annonc/mdu389] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND In a Spanish Lung Cancer Group (SLCG) phase II trial, the combination of BRCA1 and receptor-associated protein 80 (RAP80) expression was significantly associated with outcome in Caucasian patients with nonsmall-cell lung cancer (NSCLC). The SLCG therefore undertook an industry-independent collaborative randomized phase III trial comparing nonselected cisplatin-based chemotherapy with therapy customized according to BRCA1/RAP80 expression. An analogous randomized phase II trial was carried out in China under the auspices of the SLCG to evaluate the effect of BRCA1/RAP80 expression in Asian patients. PATIENTS AND METHODS Eligibility criteria included stage IIIB-IV NSCLC and sufficient tumor specimen for molecular analysis. Randomization to the control or experimental arm was 1 : 1 in the SLCG trial and 1 : 3 in the Chinese trial. In both trials, patients in the control arm received docetaxel/cisplatin; in the experimental arm, patients with low RAP80 expression received gemcitabine/cisplatin, those with intermediate/high RAP80 expression and low/intermediate BRCA1 expression received docetaxel/cisplatin, and those with intermediate/high RAP80 expression and high BRCA1 expression received docetaxel alone. The primary end point was progression-free survival (PFS). RESULTS Two hundred and seventy-nine patients in the SLCG trial and 124 in the Chinese trial were assessable for PFS. PFS in the control and experimental arms in the SLCG trial was 5.49 and 4.38 months, respectively [log rank P = 0.07; hazard ratio (HR) 1.28; P = 0.03]. In the Chinese trial, PFS was 4.74 and 3.78 months, respectively (log rank P = 0.82; HR 0.95; P = 0.82). CONCLUSION Accrual was prematurely closed on the SLCG trial due to the absence of clinical benefit in the experimental over the control arm. However, the BREC studies provide proof of concept that an international, nonindustry, biomarker-directed trial is feasible. Thanks to the groundwork laid by these studies, we expect that ongoing further research on alternative biomarkers to elucidate DNA repair mechanisms will help define novel therapeutic approaches. TRIAL REGISTRATION NCT00617656/GECP-BREC and ChiCTR-TRC-12001860/BREC-CHINA.
Collapse
Affiliation(s)
- T Moran
- Catalan Institute of Oncology, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain
| | - J Wei
- The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
| | - M Cobo
- Medical Oncology Service, Hospital Carlos Haya, Malaga
| | - X Qian
- The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
| | - M Domine
- Medical Oncology Service, Fundacion Jimenez Diaz, Madrid
| | - Z Zou
- The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
| | - I Bover
- Medical Oncology Service, Hospital Son Llatzer, Palma de Mallorca
| | - L Wang
- The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
| | - M Provencio
- Medical Oncology Service, Hospital Puerta de Hierro, Madrid, Spain
| | - L Yu
- The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
| | - I Chaib
- Catalan Institute of Oncology, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain
| | - C You
- Department of Oncology, Suqian General Hospital, Suqian, China
| | - B Massuti
- Medical Oncology Service, Hospital General de Alicante, Alicante, Spain
| | - Y Song
- Department of Pneumology, Jinling Hospital, Nanjing, China
| | - A Vergnenegre
- Service de Pathologie Respiratoire et d'Allergologie, CHU Limoges, Limoges, France
| | - H Lu
- Department of Pneumology, Taizhou General Hospital, Taizhou, China
| | | | - W Hu
- The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
| | - G Robinet
- Service Pneumologie, CHU Brest, Brest, France
| | - J Yan
- The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
| | - A Insa
- Medical Oncology Service, Hospital Clinico de Valencia, Valencia, Spain
| | - X Xu
- Department of Pneumology, Northern Jiangsu People's Hospital, Yangzhou, China
| | - M Majem
- Medical Oncology Service, Hospital Sant Pau, Barcelona, Spain
| | - X Chen
- Department of Oncology, Huaian General Hospital, Huaian, China
| | - R de Las Peñas
- Medical Oncology Service, Hospital Provincial de Castellon, Castellon, Spain
| | - N Karachaliou
- Translational Research Unit, Dr Rosell Oncology Institute, Quiron-Dexeus University Hospital, Barcelona
| | - M A Sala
- Medical Oncology Service, Hospital de Basurto, Bilbao, Spain
| | - Q Wu
- Department of Oncology, Yixin General Hospital, Yixin, China
| | - D Isla
- Medical Oncology Service, Hospital Lozano Blesa, Zaragoza, Spain
| | - Y Zhou
- Department of Oncology, Yixin General Hospital, Yixin, China
| | - N Baize
- Department de Pneumologie, CHU Angers, Angers, France
| | - F Zhang
- Department of Oncology, Maanshan General Hospital, Maanshan, China
| | - J Garde
- Medical Oncology Service, Hospital Arnau de Vilanova, Valencia, Spain
| | - P Germonpre
- Department of Pulmonary Medicine, Antwerp University Hospital, Edegem, Belgium
| | - S Rauh
- Department of Internal Medicine and Oncology, Centre Hospitalier Emile Mayrisch, Luxembourg, Luxembourg
| | - H ALHusaini
- Oncology Center, King Faisal Cancer Center, Riyadh, Saudi Arabia
| | - M Sanchez-Ronco
- Department of Health and Medicosocial Sciences, University of Alcala, Madrid
| | | | - J J Sanchez
- Department of Preventive Medicine, Autonomous University of Madrid, Madrid
| | - C Camps
- Medical Oncology Service, Hospital General de Valencia, Valencia
| | - B Liu
- The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
| | - R Rosell
- Catalan Institute of Oncology, Cancer Biology and Precision Medicine Program, Hospital Germans Trias i Pujol, Badalona; MORe Foundation, Barcelona, Spain; Cancer Therapeutic Innovation Group, New York,USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
de Gennes C, Leata C, Oliviero G, Régnard JF, Blivet S, Carpentier MC, Colby T, Bouillet L, Jeunemaitre X. Un trou peut en cacher un autre. Rev Med Interne 2014; 35:68-72. [DOI: 10.1016/j.revmed.2013.05.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2013] [Accepted: 05/27/2013] [Indexed: 12/01/2022]
|
23
|
Cadranel J, Gervais R, Antoine M, Merle P, Moro-Sibilot D, Westeel V, Bigay-Game L, Quoix E, Friard S, Barlesi F, Zaegel M, Moreau L, Monnet I, Duhamel J, Oliviero G, Souquet PJ, Thiberville L, Baudrin L, Morin F, Zalcman G. Essai IFCT-0504 : traitement de première ligne des cancers bronchiolo-alvéolaires (CBA) étendus, par erlotinib (E) ou carboplatine/paclitaxel (C/P) - impact du type cytologique mucineux (M) ou non mucineux (NM). Rev Mal Respir 2012. [DOI: 10.1016/j.rmr.2011.10.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
24
|
Cadranel J, Gervais R, Wislez M, Merle P, Moro-Sibilot D, Westeel V, Bigay-Game L, Quoix EA, Friard S, Barlesi F, Zaegel M, Moreau L, Monnet I, Duhamel J, Oliviero G, Souquet PJ, Thiberville L, Baudrin L, Morin F, Zalcman G. IFCT-0504 trial: Mucinous (M) and nonmucinous (NM) cytologic subtypes interaction effect in first-line treatment of advanced bronchioloalveolar carcinoma (BAC) by erlotinib (E) or carboplatin/paclitaxel (C/P). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7521] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
25
|
Esposito V, Oliviero G, Pepe A, Virgilio A, Galeone A. Studies on the influence of inversion of polarity sites on the dG residues glycosidic conformation in quadruplex structures. ACTA ACUST UNITED AC 2010:177-8. [PMID: 18776311 DOI: 10.1093/nass/nrn090] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Insights into the influence of inversion of polarity sites on the dG residues glycosidic conformation in quadruplexes is presented. The NMR studies concern modified oligodeoxynucleotides based on the quadruplex forming sequence TGGGT.
Collapse
Affiliation(s)
- V Esposito
- Universiti degli Studi di Napoli Federico II, Dipartimento di Chimica delle Sostanze Naturali, via D. Montesano, 49 - 80131 Napoli, Italy
| | | | | | | | | |
Collapse
|
26
|
Esposito V, Galeone A, Mayol L, Oliviero G, Virgilio A, Randazzo L. A topological classification of G-quadruplex structures. Nucleosides Nucleotides Nucleic Acids 2008; 26:1155-9. [PMID: 18058556 DOI: 10.1080/15257770701527059] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
A topological classification of most quadruplex structures is proposed, based on two main characteristics: 1) the relative orientation of the strands and 2) the nature of the loops connecting the strands.
Collapse
Affiliation(s)
- V Esposito
- Dipartimento di Chimica delle Sostanze Naturali, Università degli Studi di Napoli Federico II, Napoli, Italy
| | | | | | | | | | | |
Collapse
|
27
|
Abstract
INTRODUCTION Isolated splenic metastases from a bronchial carcinoma, without other visceral metastatic involvement, are exceptionally uncommon. CASE REPORT The authors report the finding of an isolated splenic metastasis 21 months after a left pneumonectomy for an undifferentiated large cell carcinoma, initially staged pT3N1M0. The splenic metastasis presented as a major deterioration in general health and sharp pains in the left hypochondrium. Splenectomy confirmed the metastatic nature of the splenic tumour and relieved the severe abdominal pains. Two years after the splenectomy and with out adjuvant treatment the patient remains in complete remission. CONCLUSION Splenectomy for a metastasis from a bronchial carcinoma should avoid the later complications of this type of metastasis: severe abdominal pain, splenic rupture and compression of neighbouring vessels. If the bronchial carcinoma is controlled locally and the splenic metastasis is isolated, splenectomy offers, perhaps, a further chance of prolonged survival.
Collapse
Affiliation(s)
- P Assouline
- Service de Pneumologie, Hôpital de Longjumeau, Longjumeau, France.
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Abstract
INTRODUCTION Ocular metastases are rare and their diagnosis can be difficult, being dependent on a combination of clinical examination of the eye, ultrasound, angiography and magnetic resonance imaging. CLINICAL CASE We describe two cases of cases of choroidal metastases in patients with a bronchogenic carcinoma. In both cases the metastases presented at a late stage in the disease and occurred in association with cerebral metastases. One patient had an epidermoid tumour the other a small cell carcinoma. Loss of visual acuity, which was slowly progressive in the first case and abrupt in the second, led to the diagnosis of choroidal metastases. Following radiotherapy in a dose of 30 Gray delivered to the posterior segment of the eye, both patients' visual acuity recovered to near normal within a few weeks. CONCLUSION If patients with lung cancer develop visual disturbance the possibility of choroidal metastases should be considered. Ocular radiotherapy can often ameliorate disabling visual disturbance, significantly improving quality of life.
Collapse
Affiliation(s)
- P Assouline
- Service de Pneumologie, Centre Hospitalier de Longjumeau, France.
| | | | | | | | | |
Collapse
|
29
|
Lebreton S, Assouline P, Venketasawmy S, Kardache M, Oliviero G. Une toux persistante chez un saxophoniste. Rev Mal Respir 2004; 21:158-60. [PMID: 15260052 DOI: 10.1016/s0761-8425(04)71249-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- S Lebreton
- Service de Pneumologie, Hôpital de Longjumeau, France
| | | | | | | | | |
Collapse
|
30
|
Assouline P, Bourgade J, Ezenfis J, Arrault L, Oliviero G. 105 Prévalence du « floppy eyelid syndrome » chez les patients ayant un syndrome sévère d’apnées obstructives du sommeil. Rev Mal Respir 2004. [DOI: 10.1016/s0761-8425(04)71731-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
31
|
Catalanotti B, Galeone A, Mayol L, Oliviero G, Rigano D, Varra M. Synthesis of 5-methylamino-2'-deoxyuridine derivatives. Nucleosides Nucleotides Nucleic Acids 2001; 20:1831-41. [PMID: 11719996 DOI: 10.1081/ncn-100107194] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Reductive amination of 3',5'-O-(tetraisopropyldisilyloxane-1,3-diyl)-2'-deoxy-5-formyluridine with several aliphatic and aromatic amines, in various solvents, is described. In the case of aliphatic amines, the expected C-5 substituted methylamino pyrimidine nucleosides are formed along with by-products deriving from opening of the pyrimidine ring. Relative amounts of the by-products depend upon the polarity of the solvent employed.
Collapse
Affiliation(s)
- B Catalanotti
- Dipartimento di Chimica delle Sostanze Naturali, Università degli Studi di Napoli Federico II, Italy
| | | | | | | | | | | |
Collapse
|
32
|
Galeone A, Mayol L, Oliviero G, Rigano D, Varra M. Solid-phase synthesis of oligonucleotides containing a bipyridine ligand at the 3'-3' inversion of polarity site. Bioorg Med Chem Lett 2001; 11:383-6. [PMID: 11212116 DOI: 10.1016/s0960-894x(00)00673-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
The preparation of a solid support useful for the synthesis of oligonucleotides with a 3'-3' inversion of polarity, via a linker containing a chelating molecule, namely 2,2'-bipyridine, is described.
Collapse
Affiliation(s)
- A Galeone
- Dip. di Chimica delle Sostanze Naturali, Univ. di Napoli Federico II, Italy
| | | | | | | | | |
Collapse
|
33
|
Zeggane A, Assouline PS, Tebboune D, Levasseur P, Dulmet E, Oliviero G. [Pulmonary lymphangioleiomyomatosis in a menopaused woman]. Rev Pneumol Clin 2000; 56:365-367. [PMID: 11226927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
We report an unusual case of pulmonary lymphangioleiomyomatosis in a menopaused woman who had been taking estrogen hormone replacement therapy for several years. The characteristic feature of this uncommon disease is a proliferation of non-tumoral abnormal smooth muscle cells within the alveolar walls, and around the bronchi, lymph nodes and blood vessels. About twenty cases of pulmonary lymphangioleiomyomatosis have been described in menopaused women, who generally were taking estrogen hormone replacement therapy. This subpopulation does not appear to present any particular clinical, functional or radiographic features.
Collapse
Affiliation(s)
- A Zeggane
- Service de Pneumologie, Hôpital de Longjumeau, 159 rue du Président F. Mitterrand, 91160 Longjumeau, France
| | | | | | | | | | | |
Collapse
|
34
|
Grasso L, Scarano G, Imparato E, Arace O, Oliviero G. Use of automated solid-phase extraction equipment for the determination of isoniazid in milk. Food Addit Contam 2000; 17:749-53. [PMID: 11091787 DOI: 10.1080/026520300415282] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
The possibility of using automated equipment for solid phase extraction of isoniazid from milk has been investigated. This equipment provides two noteworthy advantages: it shortens the time of analysis and avoids SPE column plugging, stabilizing flow rates. After setting the correct programme on software controlling the equipment, some validation parameters have been determined to obtain recovery and repeatability data. The mean recovery for spiked samples resulted in the range 75-95%, the standard error ranged from -5 to -20% while the RSD varied from 2 to 22%. Therefore the method can be considered reliable and fast.
Collapse
Affiliation(s)
- L Grasso
- Dipartimento di Chimica, Istituto Zooprofilattico Sperimentale del Mezzogiorno (IZSM), Portici, Italy
| | | | | | | | | |
Collapse
|
35
|
Scarano G, Esposito M, Grasso L, Soprano V, Oliviero G. Use of automated solid-phase extraction equipment for the determination of ivermectin residues in animal liver by HPLC. Analyst 1998; 123:2551-3. [PMID: 10435297 DOI: 10.1039/a805205k] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
An improvement of the method commonly used for the determination of ivermectin is proposed. An automatic system is used for the solid-phase extraction column purification stage in order to provide more efficient and fast sample preparation, prior to separation and quantification by HPLC. Some tests were performed to obtain recovery and repeatability data. The mean recovery for spiked samples (five replicates twice at three concentration levels) was more than 90% in the concentration range 7.5-30 ng g-1. The tests for accuracy (five replicates at three concentration levels) gave a standard error of -2.0% at the highest and -19.2% at the lowest concentration. Concerning repeatability data (five replicates twice at three concentration levels), in the concentration range 7.5-30 ng g-1 the RSD varied from 9.29 to 2.15%. The described method was used in a survey on the presence of ivermectin in food-producing animals in two regions of southern Italy; no positives out of 250 liver samples were found.
Collapse
Affiliation(s)
- G Scarano
- Dipartimento di Chimica, Istituto Zooprofilattico Sperimentale del Mezzogiorno (IZSM), Portici, Italy
| | | | | | | | | |
Collapse
|
36
|
Sporano V, Grasso L, Esposito M, Oliviero G, Brambilla G, Loizzo A. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet Hum Toxicol 1998; 40:141-3. [PMID: 9610490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
beta 2-adrenergic agonists, particularly clenbuterol, are illegally used as growth promoters to obtain lean in meat. Their administration in feedlots can constitute a severe risk for animal welfare and exposes consumers to involuntary drug consumption at pharmacological active concentrations. Reported poisoning episodes have been associated with the consumption of beef liver where clenbuterol residues concentrate. In August 1996, 62 persons asked for medical help at the emergency rooms of 2 hospitals near the city of Caserta (Italy). Their clinical profile was characteristic of previously occurring clenbuterol intoxication, which reported superventricular extrasystoles and atrial fibrillation. All patients had non-liver beef meat consumption 10-30 min to 2-3 h before symptoms developed. An ELISA screening test specific for clenbuterol confirmed the drug's presence. Definitive confirmation of clenbuterol and determination of the drug content in meat samples were obtained by GC-MS, using 2 different derivatization. Concentrations in the meats ranged from 0.8 to 7.4 mg/kg. These analytical data provided evidence of the seriousness of the poisoning and helped the National Health System identify other possible misinterpreted cases. This case demonstrates that clenbuterol poisoning can also occur after consumption of beef meat other than liver.
Collapse
Affiliation(s)
- V Sporano
- Dipartimento di Chimica, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Italy
| | | | | | | | | | | |
Collapse
|
37
|
Cavaliere M, Semeraro P, Anania C, Frandina G, Rea P, Pacchiarotti C, Torroni F, Oliviero G. Polychlorinated biphenyls and dichlorodiphenyl trichloroethane in human milk. A review. Eur Rev Med Pharmacol Sci 1997; 1:63-8. [PMID: 9444801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Polychlorinated biphenyls (PCBs) and dichlorodiphenyl trichloroethane (DDT) are the most frequent chemical contaminants present in human milk. Factors involving the levels of PCBs and DDT in human milk are revised. Allowable daily intake of both contaminants is indicated as well as their effect on human exposure are discussed. Since available data suggest that these contaminants are available for redistribution to the lactating mammary gland, we stress the importance of a dietary regimen to breast fed mothers in order to prevent the mobilization of body fat stores for milk fat synthesis.
Collapse
Affiliation(s)
- M Cavaliere
- Pediatric Institute, La Sapienza University, Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
38
|
de Franciscis P, Oliviero G, Greco AM. [Action of silicon on lipid metabolism]. Boll Soc Ital Biol Sper 1974; 50:577-81. [PMID: 4374961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
39
|
De Rosa G, Tinelli F, Tiberio P, Oliviero G. [Effects of histamine on plasmatic lipids]. Boll Soc Ital Biol Sper 1970; 46:702-5. [PMID: 5498689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|